Patent applications published 19 January 2011
Selected patent applications from the weekly European Patents Bulletin
- Stabilised compsns of alkylating agents and methods of using same
Yaupon Therapeutics 2273876*
- Cyclobutyl sulphones as notch sparing gamma secretase inhibitors
Merck Sharp & Dohme 2273877*
- Prolyl hydroxylase inhibitors
GlaxoSmithKline 2273879*
- Novel formulation for treatment of migraine
Zogenix 2273880*
- Compounds and methods for altering bone growth
Osteogenex 2273881*
- Bioactive compounds for treatment of cancer and neurodegenerative diseases
Poniard Pharmaceuticals 2273882*
- Proguanil to treat skin/mucosal diseases
Tolmar 2273974*
- Pharmaceutical solutions, process of preparation and therapeutic uses
UCB Pharma 2273975*
- Treatment of bladder function using liposomal botulinum toxin
Lipella Pharmaceuticals 2273976*
- Dried formulations
Zymes 2273977*
- Nanoparticle formation via rapid precipitation
Merck Sharp & Dohme 2273978*
- High-fluidity and non-caking pulverent crystalline maltitol compsn
Roquette Freres 2273979*
- Pharmaceutical compsn with bisphosphonate
Novartis 2273980*
- A solid pharmaceutical formulation
Otsuka Pharmaceutical 2273981*
- Drug depots having different release profiles for reducing, preventing and treating pain and inflammation
Warsaw Orthopaedic 2273982*
- Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of spray congealing step
Grünenthal 2273983*
- Lipid compsn
Diurnal 2273984*
- Capsule for the prevention of cardiovascular diseases
Ferrer Internacional; CNIC, Fundacion Centro Nacional de Investigaciones Cardiovasculares Carlos III 2273985*
- Encapsulation of biologically active agents
Glaxo Group 2273986*
- Film-shaped preparation comprising oily substances for oral administration
LTS Lohmann Therapie-Systeme 2273987*
- Methods and compsns for treating and identifying compounds to treat age-related macular degeneration
Arizona Board of Regents, a Body Corp of the State of Arizona, acting for and behalf of the University of Arizona 2273988*
- Combination therapy for the treatment of bacterial infections
Interface Biologics 2273989*
- Solid state forms of aliskiren compounds
Teva Pharmaceutical Industries 2273990*
- 3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction
Fabre-Kramer Pharmaceuticals 2273991*
- Quenolines and related analogues as sirtuin modulators
Sirtis Pharmaceuticals 2273992*
- Methods and compsns for the intracerebroventricular administration of felbamate
The Regents of the University of Colorado 2273993*
- Solid state forms of a pharmaceutical
Harbor Biosciences 2273994*
- Destruction of microbial products by enzymatic digestion
Baxter International; Baxter Healthcare 2273995*
- Human cardiovascular progenitor cells
Mount Sinai School of Medicine of New York University 2273996*
- Method and compsn for regenerating tissue with the aid of stem or bone marrow cells
Bader, Augustinius 2273997*
- Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents
Farallone Holdings 2273998*
- Compsn comprising polysaccharide extracted from panax ginseng preventing and treating liver disease
Korea Institute of Radiological & Medical Sciences 2273999*
- Pharmaceutical or dietetic compsn comprising and aqueous extract of Nigella sativa
Eto, Bruno 2274000*
- Heat shock protein GP96 vaccination and methods of using same
University of Miami 2274001*
- Leucine-rich peptide compsns and methods for isolation
Glanbia Nutritionals (Ireland) 2274002*
- Compsn and method for the inhibition of post-operative adhesions severity
Brandao, Jackson Lopes; Dallan, Luis Alberto Oliveira; Fundaçao, Sao Francisco Xavier 2274003*
- In vivo temporal control of activatable matrix-degrading enzymes
Halozyme 2274004*
- Treatment of tumours
Apeiron Biologics 2274005*
- Angiostatic compsns comprising truncated tyrosyl-TRNA synthetase polypeptides and methods of using same
University of North Carolina at Chapel Hill 2274006*
- Modulation of blood-brain barrier permeability
Cornell University 2274007*
- Compsns and methods for inhibiting PDGFR beta and VEGF-A
ZymoGenetics 2274008*
- Methods of treatment
GlaxoSmithKline 2274009*
- Therapeutic combinations of anti-IGF-1R antibodies and other compounds
Biogen Idec 2274010*
- An antibody bound synthetic vesicle containing active agent molecules
Banyan Biomarkers 2274011*
- Cytotoxic immunoglobulin
F-Star Biotechnologische Forschungs- und Entwicklungsges 2274012*
- Crosslinking method and cross-linked polysaccharide made thereby
Rhodia Operations 2274013*
- Stabilised oleosome preparations and method of making them
SemBioSys Genetics 2274014*
- Controlled release of active agents from oleosomes
SemBioSys Genetics 2274015*
- Use of PEGylated IGF-1 variants for the treatment of neuromuscular disorders
F Hoffmann-La Roche 2274016*
- Vascular delivery systems
Ben Gurion University of the Negev Research and Development Authority 2274017*
- Modified hydroxypolymer conjugates with bone seeking and tumour killing moieties
Dextech Medical 2274018*
- Dye solution
Fluoron 2274019*
- Process for the preparation of prostaglandin analogues and intermediates thereof
ScinoPharm Taiwan 2274266*
- Pravastatin extraction
DSM IP Assets 2274267*
- Process for the manufacture of memantine and intermediate product
Merz Pharma 2274276*
- A process for the production of nitrogen or phosphorus containing compounds from synthesis gas
University of Cape Town 2274277*
- New process for the preparation of cyclohexanecarboxylic acid derivatives
F Hoffmann-La Roche 2274278*
- Nitrix oxide donating prostamides
Nicox 2274279*
- Bis-aryl compounds for use as medicaments
Biolipox 2274280*
- HCV protease inhibitors
Taigen Biotechnology 2274281*
- Compounds for use in stabilising P53 mutants
Medical Research Council 2274282*
- Novel N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
4SC 2274283*
- Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
Vitae Pharmaceuticals 2274287*
- Macrocyclic compounds and their use as kinase inhibitors
Incyte 2274288*
- Linear and cyclic guanidine derivatives, method of preparation and uses thereof
Universita Degli Studi di Siena 2274290*
- Reactive ionic liquids
Merck Patent 2274291*
- Catalytic process for asymmetric hydrogenation
Bial-Portela 2274292*
- Method for synthesising kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
Simon Fraser University 2274293*
- 5-demethoxyfumagillol and derivatives thereof
Versitech; Morningside Ventures 2274294*
- 3,4-disubstituted piperidine derivatives as renin inhibitors
Merck Frosst Canada 2274295*
- Hydroxymethyl pyrrolidines as beta 3 adernergic receptor agonists
Merck Sharp & Dohme 2274296*
- Pyrrolidineone glucokinase activators
F Hoffmann-La Roche 2274297*
- (5R)-1,5-diaryl-4,5-dihydro-1H-pyrazole-3-carboxamidine derivatives having CB1-antagonistic activity
Abbott Healthcare Products 2274298*
- Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases
Bayer Schering Pharma 2274299*
- Novel heterocyclic compounds and uses thereof
Novartis 2274300*
- Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
Janssen Pharmaceutica 2274301*
- Compounds and compsns as ITPKB inhibitors
IRM LLC 2274302*
- Processes for preparing sunitinib and salts thereof
Teva Pharmaceutical Industries 2274303*
- Method of treating cancer using a CMET and AXL inhibitor and an ERBB inhibitor
GlaxoSmithKline 2274304*